Edition:
United Kingdom

OHR Pharmaceutical Inc (OHRP.OQ)

OHRP.OQ on NASDAQ Stock Exchange Capital Market

0.18USD
9:00pm BST
Change (% chg)

$-0.00 (-2.33%)
Prev Close
$0.18
Open
$0.19
Day's High
$0.19
Day's Low
$0.18
Volume
16,980
Avg. Vol
61,967
52-wk High
$2.17
52-wk Low
$0.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.010
Mar '18 0.00 -0.039
Dec 0.00 -0.074
FY 2017 Sep '17 0.00 -0.093
Jun '17 0.00 -0.072
Mar '17 0.00 -0.209
Dec 0.00 -0.212
FY 2016 Sep '16 0.00 -0.207
Jun '16 0.00 -0.244
Mar '16 0.00 -0.169
Dec 0.00 -0.202
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 98.72 30.39
P/E High - Last 5 Yrs. -- 271.03 47.38
P/E Low - Last 5 Yrs. -- 94.74 24.76
Beta 0.24 0.77 0.84
Price to Sales (TTM) -- 126.38 5.97
Price to Book (MRQ) 0.61 12.33 3.68
Price to Tangible Book (MRQ) 2.55 18.28 5.55
Price to Cash Flow (TTM) -- 59.02 20.84
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.38 1.79
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.46 -6.01
Payout Ratio(TTM) -- 6.12 46.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 160.40 7.40
Sales (TTM) vs TTM 1 Yr. Ago -- 92.02 6.42
Sales - 5 Yr. Growth Rate -- 24.32 7.61
EPS (MRQ) vs Qtr. 1 Yr. Ago 86.65 75.74 23.76
EPS (TTM) vs TTM 1 Yr. Ago 69.30 -- --
EPS - 5 Yr. Growth Rate -- 23.18 7.50
Capital Spending - 5 Yr. Growth Rate -32.07 36.89 8.03

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.66 2.50
Current Ratio (MRQ) 5.46 5.35 3.53
LT Debt to Equity (MRQ) 0.00 17.95 11.23
Total Debt to Equity (MRQ) 1.06 20.97 14.17
Interest Coverage (TTM) -524.34 -189.65 31.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 57.07 55.31
Gross Margin - 5 Yr. Avg. -- 52.57 53.32
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -189.87 15.82
Operating Margin (TTM) -- -674.65 3.86
Operating Margin - 5 Yr. Avg. -- -203.27 10.94
Pre-Tax Margin (TTM) -- -666.53 4.16
Pre-Tax Margin - 5 Yr. Avg. -- -204.44 11.11
Net Profit Margin (TTM) -- -656.77 0.97
Net Profit Margin - 5 Yr. Avg. -- -202.01 7.46
Effective Tax Rate (TTM) -- 11.17 20.37
Effective Tax Rate - 5 Yr. Avg. -- 18.61 24.18

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 5,094,116 721,828,383
Net Income/Employee (TTM) -3,031,400 -6,334,673 84,004,691
Receivable Turnover (TTM) -- 5.49 5.38
Inventory Turnover (TTM) -- 2.11 3.51
Asset Turnover (TTM) 0.00 0.38 0.83

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -46.83 0.13 10.03
Return on Assets - 5 Yr. Avg. -61.53 2.30 10.96
Return on Investment (TTM) -53.53 0.92 12.61
Return on Investment - 5 Yr. Avg. -70.92 1.68 14.17
Return on Equity (TTM) -53.70 -0.89 14.80
Return on Equity - 5 Yr. Avg. -70.97 -7.01 15.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 35.29 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for OHR Pharmaceutical Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.74%
# of Holders: 42
Total Shares Held: 8,324,258
3 Mo. Net Change: 189,355
# New Positions: 2
# Closed Positions: 7
# Increased Positions: 7
# Reduced Positions: 11
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.